NEJM Interviews
NEJM Group
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
Episodes
Mentioned books
Nov 18, 2015 • 10min
NEJM Interview: Dr. Paul Ginsburg on how Medicare can improve care delivery and control spending going forward.
Dr. Paul Ginsburg is a professor of the practice of health policy and management at the University of Southern California Sol Price School of Public Policy. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. P.B. Ginsburg and A.M. Rivlin. Challenges for Medicare at 50. N Engl J Med 2015;373:1993-5.
Nov 11, 2015 • 11min
NEJM Interview: Dr. Michael Lauer on peer review of NIH grant applications and how it can be improved.
Dr. Michael Lauer is deputy director for extramural research at the National Institutes of Health. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. M.S. Lauer and R. Nakamura. Reviewing Peer Review at the NIH. N Engl J Med 2015;373:1893-5.
Nov 4, 2015 • 7min
NEJM Interview: Dr. Fitzhugh Mullan on trends in the numbers of U.S. medical school graduates and GME positions.
Dr. Fitzhugh Mullan is a professor of medicine and health policy and of pediatrics at George Washington University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. F. Mullan, E. Salsberg, and K. Weider. Why a GME Squeeze Is Unlikely. N Engl J Med. DOI: 10.1056/NEJMp1511707.
Oct 28, 2015 • 7min
NEJM Interview: Dr. H. Gilbert Welch on trends in the incidence of metastatic cancers and their implications for both screening and our understanding of cancer.
Dr. H. Gilbert Welch is a professor of medicine at the Dartmouth Institute of Health Policy and Clinical Practice. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. H.G. Welch, D.H. Gorski, and P.C. Albertsen. Trends in Metastatic Breast and Prostate Cancer - Lessons in Cancer Dynamics. N Engl J Med 2015;373:1685-7.
Oct 21, 2015 • 9min
NEJM Interview: Dr. Kevin Schulman on the recent approval of two PCSK9 inhibitors and what their prices could mean for insurance premiums.
Dr. Kevin Schulman is a professor of medicine and of business administration at Duke University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. K.A. Schulman, S. Balu, and S.D. Reed. Specialty Pharmaceuticals for Hyperlipidemia - Impact on Insurance Premiums. N Engl J Med 2015;373:1591-3. B.M. Everett, R.J. Smith, and W.R. Hiatt. Reducing LDL with PCSK9 Inhibitors - The Clinical Benefit of Lipid Drugs. N Engl J Med 2015;373:1588-91.
Oct 14, 2015 • 16min
NEJM Interview: Drs. Allan Goroll and Ateev Mehrotra on whether the annual physical should be retained, eliminated, or modified for 21st-century realities.
Dr. Allan Goroll is a professor of medicine at Harvard Medical School and Massachusetts General Hospital. Dr. Ateev Mehrotra is an associate professor of Health Care Policy and Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A.H. Goroll. Toward Trusting Therapeutic Relationships - In Favor of the Annual Physical. N Engl J Med 2015;373:1487-9. A. Mehrotra and A. Prochazka. Improving Value in Health Care - Against the Annual Physical. N Engl J Med 2015;373:1485-7.
Oct 7, 2015 • 10min
NEJM Interview: Dr. David Urbach on a plan to concentrate certain surgical procedures among the physicians and hospitals that perform the most of them.
Dr. David Urbach is a professor of Surgery and of Health Policy, Management, and Evaluation at the University of Toronto. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.R. Urbach. Pledging to Eliminate Low-Volume Surgery. N Engl J Med 2015;373:1388-90.
Sep 30, 2015 • 10min
NEJM Interview: Dr. Michael Fiore on the potential for regulation of nicotine levels in cigarettes to help smokers quit.
Dr. Michael Fiore is director of the University of Wisconsin Center for Tobacco Research and Intervention. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. M. Fiore and T. Baker. Reduced-Nicotine Cigarettes - A Promising Regulatory Pathway. N Engl J Med 2015;373:1289-91.
Sep 23, 2015 • 8min
NEJM Interview: Dr. Jonathan Oberlander on the outlook for Medicare’s new physician payment system.
Dr. Jonathan Oberlander is a professor of Social Medicine and Health Policy & Management at the University of North Carolina at Chapel Hill. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Oberlander and M.J. Laugesen. Leap of Faith - Medicare’s New Physician Payment System. N Engl J Med 2015;373:1185-7. M.B. Rosenthal. Physician Payment after the SGR - The New Meritocracy. N Engl J Med 2015;373:1187-9.
Sep 16, 2015 • 8min
NEJM Interview: Dr. Christopher Robertson on the FDA’s new draft guidelines on direct-to-consumer pharmaceutical advertising.
Dr. Christopher Robertson is a professor at the James E. Rogers College of Law at the University of Arizona. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. C.T. Robertson. New DTCA Guidance - Enough to Empower Consumers? N Engl J Med 2015;373:1085-7. J.A. Greene and E.S. Watkins. The Vernacular of Risk - Rethinking Direct-to-Consumer Advertising of Pharmaceuticals. N Engl J Med 2015;373:1087-9.
